Shilajit Exercise Performance Randomized Trial: What the Evidence Says

Quick Answer

Shilajit Exercise Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 research article, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Keller et al. (2019) demonstrated that 500 mg/day of purified Shilajit extract for eight weeks reduced fatigue-induced decline in maximal voluntary isometric contraction and lowered serum hydroxyproline in recreationally active men . [Muacevic Alexander (2026); evidence level 4]
• Niranjan et al. (2016) found that Shilajit supplementation (250 mg twice daily for 12 weeks) improved endothelial function and reduced high-sensitivity C-reactive protein (hsCRP) and malondialdehyde (MDA) while increasing nitric oxide (NO) and glutathione (GSH) in patients with type 2 diabetes . [Muacevic Alexander (2026); evidence level 4]
• These effects are hypothesized to arise from enhanced fibroblast activity, increased synthesis of extracellular matrix proteins such as elastin, and reduced expression of matrix metalloproteinases (MMPs) that degrade native collagen. [Ivaskiene Tatjana (2025); evidence level 4]
• However, whileand small-scale clinical studies offer promising results, robust evidence from large randomized controlled trials (RCTs) remains limited. [Ivaskiene Tatjana (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For shilajit exercise performance randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Muacevic Alexander (2026). Safety and Efficacy of TruBlk™ Shilajit Resin Supplementation on Physical Performance and Blood Biomarkers in Healthy Adults: A 28-Day Open-Label Pilot Study. DOI: 10.7759/cureus.102372. PMCID: PMC12848467. PMID: 41613504. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12848467/
• Ivaskiene Tatjana (2025). Collagen supplementation and regenerative health: advances in biomarker detection and smart material integration. DOI: 10.3389/fnut.2025.1716166. PMCID: PMC12739960. PMID: 41459089. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12739960/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.